Journals Papers details


Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022


Author Name : ISRA' MAHMOUD KHALAF DMOUR
Title : Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022
Journal : Journal of Pharmaceutical Innovation
Year : 2022
Research Area : Compounding Pharmacy, Regulatory Affairs
Journal URL : Visit Url



Back